Human Kallikrein 6 as a Biomarker of Alzheimer’s Disease
- 1 November 2000
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 33 (8) , 663-667
- https://doi.org/10.1016/s0009-9120(00)00185-5
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Laying it on thickNature, 1999
- Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up studyJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Cerebrospinal fluid levels of Aβ42 and tau: potential markers of Alzheimer’s diseasePublished by Springer Nature ,1998
- The Pathogenesis of Senile PlaquesJournal of Neuropathology and Experimental Neurology, 1997
- Diagnostic accuracy of Alzheimer’s disease: A clinicopathological studyActa Neuropathologica, 1996
- Clinical-Neuropathological Correlations in Alzheimer's Disease and Related DementiasArchives of Neurology, 1994
- Tau protein and the neurofibrillary pathology of Alzheimer's diseaseTrends in Neurosciences, 1993
- The NINCDS‐ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's diseaseNeurology, 1988
- Amyloid plaque core protein in Alzheimer disease and Down syndrome.Proceedings of the National Academy of Sciences, 1985
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984